| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate |
2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79194c40da50565ab1e3c11412f96971 |
| publicationDate |
2005-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AR-040113-A1 |
| titleOfInvention |
METHOD FOR PRODUCING PHARMACEUTICAL DOSAGE UNITS FOR ORAL ADMINISTRATION, WHICH ETONOGESTREL INCLUDES |
| abstract |
Method for producing pharmaceutical dosage units for oral administration, comprising a progestagenic compound that orally exerts a progestagenic activity equivalent to that of the desogestrel progestogen. Claim 1: A method for reducing pharmaceutical dosage units for oral administration, comprising a progestagenic compound that orally exerts a progestagenic activity equivalent to that of the desogestrel progestogen, wherein the method comprises: (i) dissolving the progestagenic compound in a solvent organic to form a solution; (ii) mixing the resulting solution comprising the progestagenic compound with a vehicle; (iii) optionally granulate the resulting mixture; (iv) dry the mixture: (v) combine the mixture with excipients; and (vi) convert the resulting mixture into dosage units, characterized in that the progestagenic compound is etonogestrel. |
| priorityDate |
2002-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |